Form 4: Sensient Technologies Director Carleone Reports Stock Acquisition

Sentiment:

SEC Form 4 Filing


Director Joseph Carleone reports acquisition of deferred stock convertible to common stock in Sensient Technologies Corp.

Summary

  • On March 31, 2024, Joseph Carleone, a director of Sensient Technologies Corp, acquired 527.894 shares of deferred stock.
  • This deferred stock is convertible to common stock on a one-for-one basis and was acquired through deferral of director fees under the Issuer's Directors' Deferred Compensation Plan.
  • The shares of common stock will be issued upon termination of Carleone's service as a director.
  • Following the transaction, Carleone beneficially owns 18,143.583 shares of common stock and 19,442.127 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company, aligning interests with shareholders. It's a routine transaction, so the impact is moderate.

Positives

  • The acquisition of deferred stock indicates continued alignment of the director's interests with the company's long-term performance.

Future Outlook

Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's continued investment in the company.

Key Dates

DateDescription
03/31/2024Date of transaction: acquisition of deferred stock.
04/01/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.